Profile
Tausif Butt currently works at Navigator Medicines, Inc., as Chief Executive Officer from 2025.
Mr. Butt also formerly worked at AstraZeneca PLC, as Senior Vice President-Latin America from 2019 to 2021, ChemoCentryx, Inc., as Chief Operating Officer & Executive Vice President from 2021 to 2022, and Idorsia Pharmaceuticals US, Inc., as President & General Manager.
Mr. Butt received his graduate degree from Imperial College London and undergraduate degree from the University of Brighton.
Tausif Butt active positions
| Companies | Position | Start |
|---|
Former positions of Tausif Butt
| Companies | Position | End |
|---|---|---|
| CHEMOCENTRYX, INC. | Chief Operating Officer | 2022-10-19 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 2020-12-31 |
Idorsia Pharmaceuticals US, Inc. | President | - |
Training of Tausif Butt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Brighton
University of Brighton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idorsia Pharmaceuticals US, Inc. | Health Technology |
- Stock Market
- Insiders
- Tausif Butt
















